HOME >> BIOLOGY >> NEWS
Wiley-VCH and EFIS expand collaboration

September 18, 2006, Weinheim, Germany -- Wiley-VCH Verlag, the Executive Committee (ExCo) of the European Journal of Immunology (EJI), and the European Federation of Immunological Societies (EFIS) announced today that they have entered into an expanded new publishing agreement, designed to make the European Journal of Immunology the foremost international immunology journal published in Europe. Edited under the auspices of EFIS, EJI will focus on publishing a broad spectrum of high-quality scientific research from around the world.

On a rotating basis, new editors representing the range of subject fields covered in the journal will be jointly invited by EFIS and Wiley-VCH to serve as ExCo members of the journal with the aim of ensuring a rapid and high standard peer-review of submitted papers. Professor Rolf Zinkernagel, who has served as Chair of the ExCo with distinction and enthusiasm over the past seven years, will continue his work for the journal until the end of 2007. He will be supported by two deputies, to be appointed shortly, one from the U.S. and one from Australasia/Asia.

"This is a new beginning, one that we all look forward to with great enthusiasm" said Professor Foo Yoo Liew, Past-President of EFIS.

Stefan H. E. Kaufmann, the new President of EFIS, is excited about the tremendous opportunities that arise through this agreement: "All aspects of European immunology including education, public awareness and science will benefit enormously from this arrangement."

"The real winner of this new collaboration agreement is the scientific community, as profits from the journal will be used to aid and support the immunology research community and to sponsor scientific events," said Dr. Manfred Antoni, Managing Director of Wiley-VCH. All such charitable activities will be administered by EFIS and will be publicly announced in the journal and in EFIS communications.


'"/>

Contact: Dr. Cate Livingstone
Clivings@wiley-vch.de
49-062-016-06449
John Wiley & Sons, Inc.
18-Sep-2006


Page: 1

Related biology news :

1. EMBL expands to Australia
2. Genomatix expands operations in North America
3. PET/CT use expands: Effectively diagnosing graft infections
4. Salmon tracking program expands to California
5. Wilson Center and Pew Charitable Trusts expand efforts to examine risks/benefits of nanotechnology
6. Scientists expand microbe gene language
7. ResearchChannel expands delivery for its extensive online video library
8. Lehigh scientist receives NHGRI grant to streamline, expand use of genome sequencing
9. Springer expands life science program with In Vitro journals
10. Male contraceptive study expands to 4 US cities
11. $20 million to expand seafloor observatory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: